Related Experiment Videos
Retroperitoneoscopic live donor nephrectomy: extended experience in a single center.
K Tanabe1, N Miyamoto, T Tokumoto
1Section of Renal Transplantation/Renovascular Surgery, Department of Urology, Tokyo Women's Medical University, Tokyo, Japan. tanabe@kc.twmu.ac.jp
Transplantation Proceedings
|November 3, 2004
Summary
Retroperitoneoscopic live donor nephrectomy (RPLDN) offers a less invasive alternative to open procedures. This study found RPLDN resulted in shorter hospital stays and reduced painkiller use compared to open donor nephrectomy.
Area of Science:
- Nephrology
- Minimally Invasive Surgery
- Transplantation
Background:
- Retroperitoneoscopic live donor nephrectomy (RPLDN) is explored as a less invasive surgical approach.
- Compared to open live donor nephrectomy (OLDN) and transperitoneal laparoscopic methods.
- This study evaluates the safety and efficacy of RPLDN.
Purpose of the Study:
- To compare the outcomes of retroperitoneoscopic live donor nephrectomy (RPLDN) with open live donor nephrectomy (OLDN).
- To assess the impact of surgical approach on operative time, postoperative pain, and hospital stay.
Main Methods:
- 118 live donor kidney procurements were analyzed between July 2001 and May 2003.
- Patients were divided into two RPLDN groups (initial and subsequent) and one OLDN control group.
- Kidney retrieval methods varied between RPLDN groups, utilizing flank or Pfannenstiel incisions.
Main Results:
- RPLDN demonstrated significantly shorter operative times (245 min) and reduced postoperative painkiller requirements (4.4 mg) compared to OLDN (215 min, 22 mg) and initial RPLDN (307 min, 12 mg).
- Hospital stay was significantly reduced with RPLDN (4.9 days) compared to OLDN (7.0 days) and initial RPLDN (6.6 days).
- No serious complications like massive bleeding or bowel injury were reported in any group.
Conclusions:
- Retroperitoneoscopic live donor nephrectomy (RPLDN) appears to be a safer and less invasive option for kidney procurement.
- The technique shows promise in reducing patient recovery time and discomfort.
- Further research may solidify RPLDN as a preferred method for live donor nephrectomy.